用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网科技动向学人动向
关键字  范围   
 
USC geneticist Marlena Fejzo named one of Time magazine’s 2024 ‘Women of the Year’
2024/3/19 10:35:35 | 浏览:701 | 评论:0

USC geneticist Marlena Fejzo named one of Time magazine’s 2024 ‘Women of the Year’

Marlena Fejzo of the Keck School of Medicine of USC has been named one of Time magazine’s 2024 “Women of the Year.”(Photo/Christina Gandolfo)


The recognition follows the Keck School of Medicine professor’s recent study that showed that a hormone produced by the fetus triggers nausea and vomiting during pregnancy.

February 21, 2024
By Leigh Hopper
USC geneticist Marlena Fejzo, whose discovery of the cause of morning sickness in pregnancy brought international attention to her work, is one of Time magazine’s 2024 “Women of the Year,” the publication announced Wednesday.

The recognition follows Fejzo’s recent study in Nature that showed that a hormone produced by the fetus — and the mother’s sensitivity to it — triggers nausea and vomiting during pregnancy.

Up to 80% of pregnant women experience morning sickness, more accurately known as pregnancy sickness since it can occur at any time of day. Another 2% are affected by a severe form called hyperemesis gravidarum, or HG, which can cause dehydration, weight loss, electrolyte imbalances and hospitalization.

“Dr. Fejzo’s persistence in understanding HG, and her exceptional research, has advanced our understanding of the biology of HG, which is information that will be used to improve health outcomes for both mothers at risk and their children,” said Christopher Haiman, director of the Center for Genetic Epidemiology at the Keck School of Medicine of USC.

Fejzo’s life’s work
Fejzo, who joined Haiman’s Center for Genetic Epidemiology last year, endured HG herself. For months in 1999, pregnant with her second child, she suffered intense nausea, unable to keep anything down. As she literally starved and became too weak to stand, her doctor floated theories about the cause:It was psychological, a bid for sympathy from her husband or a way to get attention from her parents.

At 15 weeks, she lost the pregnancy.

Finding the cause of her condition became her life’s work.

Despite the severity of the condition — which includes the potential for maternal death — few scientists study it, and, historically, funding is difficult to find. The National Institutes of Health has funded only six hyperemesis studies since 2007. Fejzo, whose day job at UCLA at the time was studying ovarian cancer, chipped away at the HG puzzle during her evenings and weekends.

A major breakthrough
A breakthrough came when the 23andMe DNA testing company agreed, at Fejzo’s request, to include a few questions about hyperemesis in a survey. A few years later, she worked with the company to scan the genetic data of more than 50,000 research participants for genes associated with pregnancy sickness.

The results pointed to a specific gene, one that encodes a hormone called GDF15.

Subsequent work suggested two possible solutions for pregnancy sickness:a treatment that could lower levels of the hormone GDF15 during pregnancy, or a preventive effort that would involve exposing the woman to the hormone before pregnancy.

What’s next? Fejzo is applying for funding to test whether metformin, a drug that increases GDF15 levels and could thus “prime” the patient, could be taken prior to pregnancy and prevent or lower the risk of HG.

A newly formed company, Materna Biosciences, recruited Fejzo as its chief scientific advisor as it develops a GDF15-based drug for HG. Several such drugs are already in clinical trials for cachexia, a condition that causes severe weight loss in patients with cancer.

Fighting bias and looking for a cure
Fejzo is pleased by Time’s “Women of the Year” designation, but she mostly hopes to raise greater awareness about the condition — and find better treatments or a cure.

“There continues to be bias. I spoke to a doctor this week who has a patient hospitalized,” Fejzo said. “Besides him, the whole rest of the team dismissed her inability to eat as depression. As soon as they gave her steroids, her nausea and vomiting lifted, she ate, and immediately her mood improved.

“I hope the recognition from Time inspires more women to go into science because hyperemesis is not the only condition that’s under researched,” Fejzo said. “We just need more women scientists out there.”


相关栏目:『学人动向
朱民:中国经济将面临巨大的结构性变化! 2024-11-06 [87]
巫宁坤:活下去,并且“在日暮时燃烧咆哮” 2024-11-04 [105]
周其仁:中国经济高位下行的根本原因 2024-11-03 [127]
张维迎:让我最痛心的是社会变得如此虚伪,如此假话连篇 2024-10-31 [173]
达龙·阿西莫格鲁:制度视角下的中国未来经济增长 2024-10-31 [148]
钱满素:献身精神本身不足以成为一种美德 2024-10-31 [150]
战争琐思录(一):关于诺娃 2024-10-31 [145]
​“中产阶级气质”批判——关于当代中国知识者精神状态的一份札记 2024-10-27 [290]
后生可畏!这位华裔才俊掌控着全球顶尖公司AI模型训练! 2024-10-21 [374]
钱理群:安贫乐道是伪精英最愚蠢的理念等六则 2024-10-21 [396]
相关栏目更多文章
最新图文:
:天安门广场喜迎“十一”花团锦簇的美丽景象 马亮:做院长就能够发更多论文?论文发表是不是一场“权力的游戏”? :印裔人才在美碾压华裔:我们可以从印度教育中学到什么? :北京452万人将从北京迁至雄安(附部分央企名单) :《2019全球肿瘤趋势报告》 :阿尔茨海默病预防与干预核心讯息图解 :引力波天文台或有助搜寻暗物质粒子 :Sail Through the Mist - SoCal Innovation Forum 2019(10/5)
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2024 ScholarsUpdate.com. All Rights Reserved.